← Back to headlines
AstraZeneca's $1.5 billion lung cancer investment
AstraZeneca has made a significant $1.5 billion investment in lung cancer research and development, with questions arising about whether its new drug Zegfrovy can bolster its oncology growth.
23 Aug, 19:38 — 23 Aug, 19:38
Sources
Showing 1 of 1 sources
Related Stories
Rising Oil Prices Drive Up Bond Yields and Trigger Equity Sell-Offs
59m ago
Global Bond Selloff Deepens as Yields Rise Amid Geopolitical Tensions
1h ago
N1 and CNN Confirm Expiration of Broadcasting Partnership Agreement
1h ago
U.S. Equity Markets See Midday Swings Led by Palo Alto Networks Activity
1h ago